Risk factors
Vertex Pharmaceuticals (VRTX) risk factors
Item 1A of every Vertex Pharmaceuticals Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors35 risks24 new37 dropped11 reworded
CF medicines still generate substantially all net product revenue, making manufacturing, safety, competition, and reimbursement especially consequential.
Filed Feb 13, 2026 - FY2024 10-K risk factors50 risks
CF medicines generate substantially all recent net product revenue, making continued CF sales the company’s dominant financial dependency.
Filed Feb 13, 2025